Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data Falcon's Beyond Global, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2023
FY2023
FY2024
FY2025
Revenue
16
18.2
6.75
14.9
Research and development
2.77
1.25
0.18
Selling, general and administrative
18.4
28.1
22.4
25.5
Operating expenses
33.3
75.4
22.6
28.3
Operating income
-17.3
-57.2
-15.9
-13.4
Interest expense
1.11
1.12
1.9
3.38
Interest income
0.1
0.01
0.01
Pre-tax income
-17.4
-431
149
6.31
Income tax
-0.33
0
-0
Net income to minority interests
-383
127
3.47
Net income
-17.4
-47.6
22.1
2.84
EBITDA
-16.6
-55.6
-15.9
-13.1
EPS, basic
-5.59
1.76
0.06
EPS, diluted
-5.59
1.41
0.03
Shares, basic (weighted)
8.51
12.5
39.2
Shares, diluted (weighted)
8.51
12.7
39.3
Balance sheet
FY2023
FY2023
FY2024
FY2025
Cash and equivalents
8.37
0.67
0.83
1.87
Receivables
3.31
0.7
1.72
3.71
Inventory
0.41
Other current assets
0.84
1.06
1.59
1.53
Total current assets
17.5
2.43
4.13
10.4
Property, plant and equipment
0.8
0.02
0.02
1.02
Lease right-of-use assets
1
0
3.19
Goodwill
11.5
Intangible assets
8.3
0
1.06
Other non-current assets
0.67
0.26
0.51
0.34
Total assets
112
63.4
61.2
66.7
Accounts payable
4.63
3.85
9.54
8.45
Accrued liabilities
20.8
25.9
16.4
Deferred revenue
1.3
0
0.02
Short-term debt
7.41
6.65
10.2
3.16
Total current liabilities
17.3
214
45.6
28.5
Long-term debt
25.7
23
31
12.5
Lease liabilities
0.85
0
1.9
Other non-current liabilities
5.5
Total liabilities
43.9
552
81.3
42.9
Total debt
33.1
6.65
41.2
15.6
Paid-in capital
11.7
37.8
55.8
Retained earnings
-24.1
-68.6
-46.5
-44.2
Other comprehensive income
-1.69
-0.22
-0.24
0.39
Shareholders' equity
68.4
-57.1
-8.97
11.9
Minority interests
-432
-11.1
11.9
Total equity
68.4
-489
-20.1
23.8
Total liabilities and equity
112
63.4
61.2
66.7
Shares outstanding
0
Cash flow statement
FY2023
FY2023
FY2024
FY2025
Net income
-17.4
-431
149
6.31
Depreciation and amortization
0.74
1.58
0.01
0.35
Stock-based compensation
0.07
1.5
1.66
Deferred income tax
-0.03
0
Change in receivables
0.39
-3.83
-1.06
-2.09
Change in inventory
0.2
Change in payables
4.31
3.79
7.2
-1.49
Cash from operations
-19.3
-23.4
-12.6
-24.6
Capital expenditures
-0.32
-0.31
-0.01
-0.15
Acquisitions
0
-1.63
Cash from investing
-26.3
0.28
-0.01
24.2
Cash from financing
50.9
15.1
12.9
3.71
Exchange rate effect
-0.06
0.31
-0.14
-2.25
Net change in cash
5.33
-8.01
0.29
3.29
Free cash flow
-19.6
-23.7
-12.6
-24.8
Interest paid
0.61
1.34
0.52
3.05
Income taxes paid
0
0.1
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $7.43 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
2.3%
Operating income / revenue.
EBITDA margin
5.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-22.7%
Pre-tax income / revenue.
Net margin
-8.6%
Net income / revenue.
FCF margin
-83.5%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-83.2%
Cash from operations / revenue.
Return on equity (ROE)
-12.4%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-2.9%
Net income / average total assets.
Return on invested capital (ROIC)
1.4%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue
129.2%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
10.0%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.3%
Capital expenditures / revenue.
D&A / revenue
2.6%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
120.8%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-2.3%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y
-87.1%
Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y
-97.9%
EPS vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-44.1%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
8.9%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-15.9%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y
208.5%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.66x
Current assets / current liabilities.
Quick ratio
0.35x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.13x
(Cash + short-term investments) / current liabilities.
Debt / equity
1.05x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
24.9%
Total debt / total assets.
Liabilities / assets
53.0%
Total liabilities / total assets.
Net debt
$12.7M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA
11.8x
Net debt / EBITDA (twelve months), when EBITDA is positive.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.44
Revenue / diluted weighted shares.
FCF per share
-$0.37
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.36
Cash from operations / diluted weighted shares.
Book value per share
$0.31
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
41.6x
Market cap / revenue.
P/B
59.8x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
63.9x
Market cap / tangible book value, when positive.
EV/Sales
42.2x
Enterprise value / revenue.
EV/EBIT
1,799x
Enterprise value / operating income, when both are positive.
EV/EBITDA
848x
Enterprise value / EBITDA, when both are positive.
FCF yield
-2.0%
Free cash flow / market cap.
Earnings yield
-0.2%
Net income / market cap (the inverse of P/E).
What was Falcon's Beyond Global, Inc.'s revenue in fiscal 2025?
Falcon's Beyond Global, Inc. reported revenue of $14.9M for fiscal 2025, 120.8% higher than the year before.
Was Falcon's Beyond Global, Inc. profitable in fiscal 2025?
Yes. Net income was $2.8M, a net margin of 19.1%.
How much free cash flow did Falcon's Beyond Global, Inc. generate in fiscal 2025?
Cash from operations of $24.6M minus capital expenditures of $153.0K left free cash flow of -$24.8M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.